Partnerships and Collaborations
Landmark Vaccines is a next-generation vaccine company dedicated to transforming how infectious diseases and immune disorders are prevented and treated. Our mission is to make immunisation simpler, safer, and more effective - harnessing both proven and emerging vaccine technologies to protect global populations.
AT THE FOREFRONT
OF VACCINE TECHNOLOGY
We actively collaborate with academic institutions, biotechnology companies, and public health agencies to translate innovation into impact.
Our open-innovation model enables partnerships in:
- Antigen design and vaccine formulation
- mRNA and DNA payload optimisation
- Pre-clinical and clinical testing
- Co-development of vaccines for specific pathogens or therapeutic indications
Landmark Vaccines welcomes strategic collaborations to accelerate the development of both preventive and therapeutic vaccines, globally.
JOIN US IN SHAPING THE FUTURE OF IMMUNISATION
At Landmark Vaccines, we believe the future of vaccination lies in precision delivery, global accessibility, and scientific collaboration.
Through our dual expertise in microneedle and cell-penetrating delivery technologies, we are building a pipeline of next-generation vaccines and immune therapies that can change the way the world thinks about immunisation.
We invite partners, investors, and collaborators to join us in advancing this mission - delivering protection, performance, and progress through innovation.
